MedPath

To evaluate and compare the efficacy of 18F-FDG PET taken in hyperglycemic state, 18F-FDG PET taken in NPO state, and C-11 acetate PET in detecting and grading brain tumor

Not Applicable
Completed
Conditions
Neoplasms
Registration Number
KCT0004466
Lead Sponsor
Yonsei University Health System, Severance Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
73
Inclusion Criteria

1. Adult men and women over the age of 20
2. First diagnosed primary brain tumor patient
3. Patients scheduled to undergo cancer resection as their primary treatment

Exclusion Criteria

1. Patients who have undergone chemotherapy or radiation therapy for pretreatment
2. A pregnant patient
3. Patients or guardians who do not understand or do not accept consent
4. Uncontrolled diabetes

Study & Design

Study Type
Interventional Study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath